Latest Intellectual Property News

Page 49 of 56
Echo IQ Limited marked a pivotal quarter with FDA clearance for EchoSolv AS, strategic US partnerships, and a clear path toward reimbursement and broader commercialisation.
Ada Torres
Ada Torres
29 Apr 2025
Immutep Limited has dosed the first patient in its pivotal Phase III lung cancer trial and completed enrolments in multiple studies, supported by a robust cash position expected to fund operations through 2026.
Ada Torres
Ada Torres
29 Apr 2025
Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.
Ada Torres
Ada Torres
29 Apr 2025
Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.
Victor Sage
Victor Sage
29 Apr 2025
Everest Metals Corporation has launched a major aircore drilling campaign at its Revere Gold Project while advancing a pioneering rubidium extraction patent at Mt Edon, setting the stage for resource growth and near-term mining at Mt Dimer.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Prime Financial Group has agreed to acquire Lincoln Indicators, a leading Australian investment research and funds management firm, significantly boosting its wealth management capabilities and client base.
Claire Turing
Claire Turing
22 Apr 2025
Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.
Ada Torres
Ada Torres
18 Feb 2025
Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.
Victor Sage
Victor Sage
18 Feb 2025
Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.
Ada Torres
Ada Torres
17 Feb 2025
Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.
Maxwell Dee
Maxwell Dee
14 Feb 2025
Infomedia Ltd has agreed to acquire a 50% stake in European AI startup Intellegam GmbH for €6.1 million, marking a strategic leap to integrate cutting-edge generative AI into its automotive data solutions. The deal sets a clear path to full ownership within five years, underpinning Infomedia’s innovation-driven growth agenda.
Sophie Babbage
Sophie Babbage
14 Feb 2025
AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.
Ada Torres
Ada Torres
14 Feb 2025